1188 GS-6620, A LIVER-TARGETED NUCLEOTIDE PRODRUG, EXHIBITS ANTIVIRAL ACTIVITY AND FAVORABLE SAFETY PROFILE OVER 5 DAYS IN TREATMENT NAIVE CHRONIC HCV GENOTYPE 1 SUBJECTS
Lawitz, E, Hill, J, Marbury, T, Hazan, L, Gruener, D, Webster, L, Majuskas, R, Morrison, R, DiMcco, M, German, P, Stefanidis, D, Svaroskaia, E, Jain, A, Arterburn, S, Ray, A, Rossi, S, McHutchson, J, Rodriguez-Torres, M
Published in Journal of hepatology (01.04.2012)
Published in Journal of hepatology (01.04.2012)
Get full text
Journal Article